Skip to content

Author

Alexander Heifetz

We have 4 of 67 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

2026

Beyond Small Molecules: Applying Fragment Molecular Orbital Sygnature Platform (FMO-SP) to Emerging Modalities.

The Fragment Molecular Orbital Sygnature Platform (FMO-SP) integrates quantum mechanics with automated workflows and intuitive visual analytics to provide residue-level, quantified energetic insights, supporting more predictive and resource-efficient drug discovery.

Alexander Heifetz, Girinath G. Pillai, Maryamdokht Taimoory et al. · 0 citations
Review 2026

Perspectives on Hybridizing Quantum Mechanics and Artificial Intelligence for Drug Design.

This chapter presents the perspective of computational chemists at Sygnature Discovery on the growing need to integrate quantum mechanics (QM) with artificial intelligence (AI) to improve the efficiency and effectiveness of modern drug design.

Alexander Heifetz, Girinath G. Pillai, M. Quareshy et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.